Search research articles
Contact Us
Filters
Showing results (21-30 of 35) with videos related to
Page
of 4
Sort By:
The Journal of Clinical Endocrinology and Metabolism
|
February 19, 1998
Simulated microgravity increases beta-adrenergic lipolysis in human adipose tissue
P Barbe, J Galitzky, I De Glisezinski, et al.
Neurology
|
May 9, 2001
Dual-release formulation, a novel principle in L-dopa treatment of Parkinson's disease
S Descombes, A M Bonnet, U E Gasser, et al.
Journal of the American Society of Nephrology : JASN
|
December 16, 1998
Pharmacokinetics of alphaIFN-2b in chronic hepatitis C virus patients undergoing chronic hemodialysis or with normal renal function: clinical implications
L Rostaing, E Chatelut, J L Payen, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
December 2, 2000
Triiodothyronine-mediated up-regulation of UCP2 and UCP3 mRNA expression in human skeletal muscle without coordinated induction of mitochondrial respiratory chain genes
P Barbe, D Larrouy, C Boulanger, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme
|
May 8, 2003
Post-exercise increase of lipid oxidation after a moderate exercise bout in untrained healthy obese men
F Marion-Latard, F Crampes, A Zakaroff-Girard, et al.
La Revue De Medecine Interne
|
October 20, 2020
Clinical characteristics and outcome of hospitalized patients with SARS-CoV-2 infection at Toulouse University hospital (France). Results from the Covid-clinic-Toul cohort
A Jourdes, M Lafaurie, G Martin-Blondel, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
August 1, 1998
Efaroxan, an alpha-2 antagonist, in the treatment of progressive supranuclear palsy
O Rascol, K Sieradzan, H Peyro-Saint-Paul, et al.
British Journal of Clinical Pharmacology
|
May 13, 1998
Effect of food on the pharmacokinetics of ropinirole in parkinsonian patients
C Brefel, C Thalamas, S Rayet, et al.
European Journal of Neurology
|
April 19, 2006
Sleep disruption, daytime somnolence and 'sleep attacks' in Parkinson's disease: a clinical survey in PD patients and age-matched healthy volunteers
J J Ferreira, K Desboeuf, M Galitzky, et al.
Annals of Neurology
|
June 9, 1999
ABT-431, a D1 receptor agonist prodrug, has efficacy in Parkinson's disease
O Rascol, O Blin, C Thalamas, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 35) with videos related to
Sort By:
Page
of 4
The Journal of Clinical Endocrinology and Metabolism
|
February 19, 1998
Simulated microgravity increases beta-adrenergic lipolysis in human adipose tissue
P Barbe, J Galitzky, I De Glisezinski, et al.
Neurology
|
May 9, 2001
Dual-release formulation, a novel principle in L-dopa treatment of Parkinson's disease
S Descombes, A M Bonnet, U E Gasser, et al.
Journal of the American Society of Nephrology : JASN
|
December 16, 1998
Pharmacokinetics of alphaIFN-2b in chronic hepatitis C virus patients undergoing chronic hemodialysis or with normal renal function: clinical implications
L Rostaing, E Chatelut, J L Payen, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
December 2, 2000
Triiodothyronine-mediated up-regulation of UCP2 and UCP3 mRNA expression in human skeletal muscle without coordinated induction of mitochondrial respiratory chain genes
P Barbe, D Larrouy, C Boulanger, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme
|
May 8, 2003
Post-exercise increase of lipid oxidation after a moderate exercise bout in untrained healthy obese men
F Marion-Latard, F Crampes, A Zakaroff-Girard, et al.
La Revue De Medecine Interne
|
October 20, 2020
Clinical characteristics and outcome of hospitalized patients with SARS-CoV-2 infection at Toulouse University hospital (France). Results from the Covid-clinic-Toul cohort
A Jourdes, M Lafaurie, G Martin-Blondel, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
August 1, 1998
Efaroxan, an alpha-2 antagonist, in the treatment of progressive supranuclear palsy
O Rascol, K Sieradzan, H Peyro-Saint-Paul, et al.
British Journal of Clinical Pharmacology
|
May 13, 1998
Effect of food on the pharmacokinetics of ropinirole in parkinsonian patients
C Brefel, C Thalamas, S Rayet, et al.
European Journal of Neurology
|
April 19, 2006
Sleep disruption, daytime somnolence and 'sleep attacks' in Parkinson's disease: a clinical survey in PD patients and age-matched healthy volunteers
J J Ferreira, K Desboeuf, M Galitzky, et al.
Annals of Neurology
|
June 9, 1999
ABT-431, a D1 receptor agonist prodrug, has efficacy in Parkinson's disease
O Rascol, O Blin, C Thalamas, et al.
Page
of 4